News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,382 Results
Type
Article (88911)
Company Profile (723)
Press Release (795729)
Multimedia
Podcasts (243)
Webinars (36)
Section
Business (233648)
Career Advice (4164)
Deals (40020)
Drug Delivery (181)
Drug Development (91769)
Employer Resources (207)
FDA (18591)
Job Trends (17496)
News (398863)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (56990)
ALS (242)
Alzheimer's disease (1998)
Antibody-drug conjugate (ADC) (584)
Approvals (18980)
Artificial intelligence (904)
ASCO (345)
Autoimmune disease (381)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (256)
Biotechnology (432)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (858)
Cancer (6767)
Cardiovascular disease (570)
Career advice (3601)
Career pathing (53)
CAR-T (394)
CDC (77)
Celiac Disease (3)
Cell therapy (1102)
Cervical cancer (58)
Clinical research (79320)
Collaboration (2444)
Commercialization (1)
Company closure (8)
Compensation (1577)
Complete response letters (110)
COVID-19 (3045)
CRISPR (128)
C-suite (1345)
Cystic fibrosis (169)
Data (8934)
Decentralized trials (3)
Denatured (93)
Depression (202)
Dermatology (101)
Diabetes (722)
Diagnostics (7634)
Digital health (73)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (458)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (331)
Earnings (102544)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (138944)
Executive appointments (1221)
FDA (22830)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2012)
Gene editing (279)
Generative AI (92)
Gene therapy (867)
GLP-1 (1296)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21273)
Hematology (198)
HIV (100)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (118)
Immunology and inflammation (365)
Immuno-oncology (121)
Indications (225)
Infectious disease (3454)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (155)
Intellectual property (332)
Interviews (822)
IPO (18011)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (695)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (891)
Lymphoma (488)
Machine learning (70)
Management (68)
Manufacturing (1289)
Marketing (4)
MASH (231)
Medical affairs (1)
Medical device (15307)
Medtech (15491)
Mergers & acquisitions (23356)
Metabolic disorders (1866)
mRNA (277)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (528)
Neuropsychiatric disorders (132)
Neuroscience (3804)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (887)
Opinion (381)
Ovarian cancer (252)
Pain (290)
Pancreatic cancer (374)
Parkinson's disease (429)
Partnered (42)
Patents (681)
Patient recruitment (813)
Peanut (72)
People (68166)
Pharmaceutical (114)
Pharmacy benefit managers (38)
Phase 1 (24512)
Phase 2 (34457)
Phase 3 (25908)
Pipeline (10231)
Policy (405)
Postmarket research (3560)
Preclinical (11003)
Press Release (72)
Prostate cancer (355)
Psychedelics (73)
Radiopharmaceuticals (378)
Rare diseases (1326)
Real estate (7463)
Recruiting (82)
Regulatory (30631)
Reports (77)
Research institute (2776)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (345)
Series B (251)
Service/supplier (24)
Sickle cell disease (132)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4376)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (147)
Vaccines (1335)
Venture capital (142)
Weight loss (605)
Women's health (147)
Worklife (25)
Date
Today (62)
Last 7 days (469)
Last 30 days (2248)
Last 365 days (33204)
2026 (17839)
2025 (33217)
2024 (38030)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (101)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52423)
Australia (9212)
California (14646)
Canada (4116)
China (1639)
Colorado (630)
Connecticut (651)
Delaware (453)
Europe (120885)
Florida (2194)
Georgia (475)
Hawaii (4)
Idaho (70)
Illinois (1286)
India (108)
Indiana (673)
Iowa (27)
Japan (624)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1769)
Massachusetts (10730)
Michigan (428)
Minnesota (818)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (157)
New Hampshire (92)
New Jersey (3879)
New Mexico (35)
New York (3869)
North Carolina (1965)
North Dakota (11)
Northern California (7307)
Ohio (460)
Oklahoma (27)
Oregon (55)
Pennsylvania (2872)
Puerto Rico (33)
Rhode Island (56)
South America (1669)
South Carolina (90)
South Dakota (2)
Southern California (5765)
Tennessee (240)
Texas (2396)
United States (52414)
Utah (438)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1197)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 885,382 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trenchant Technologies Capital Corp. Announces Private Placement Offering of up to $1 Million Convertible Debentures
July 6, 2026
·
4 min read
Press Releases
Pulmongene Appoints Hunter C. Gillies, M.B.Ch.B, as Chief Medical Officer to Lead Global Clinical Development in Fibrotic and Pulmonary Diseases
— Veteran Physician-Scientist Brings Over 25 Years of Pulmonary and Cardiopulmonary Clinical Development Leadership Spanning Pfizer, Gilead, and Aerovate Therapeutics —
July 6, 2026
·
1 min read
IPO
Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom
After debuting on the public markets with $256.3 million and raking in an additional
$472 million
, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the weight loss craze for establishing consumer-driven channels.
July 6, 2026
·
5 min read
·
Gabrielle Masson
Press Releases
Codis To Acquire Catalent’s Nottingham, UK Facility to Create Europe’s Leading End-to-End Spray Dry Capability
July 6, 2026
·
2 min read
Press Releases
Nexsphere-F™ Clinical Study Published in Radiology, Showing 57% Reduction in Knee Osteoarthritis Pain
July 6, 2026
·
2 min read
Press Releases
Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, “Focused Discussions on Overseas Out-Licensing Deals”
July 6, 2026
·
2 min read
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
With the latest round, Roche’s Genentech will have racked up nearly 450 layoffs in California over the last year amid ongoing restructuring. At the same time, the biotech is joining forces with Astex Pharmaceuticals in a deal that could surpass $490 million.
July 6, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
July 6, 2026
·
5 min read
Press Releases
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™
July 6, 2026
·
3 min read
Press Releases
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
July 6, 2026
·
7 min read
1 of 88,539
Next
